國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 906014      在线人数 : 630
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    主页登入上传说明关于NHRI管理 到手机版

    子类别

    專利 [0/32]
    期刊論文 [143/144]
    會議論文/會議摘要 [27/39]

    邻近社群


    伍素瑩 [52/65]
    其他 [58/60]
    夏克山 [76/98]
    岳嶽 [29/32]
    張仲明 [7/9]
    張俊彥 [18/18]
    張竣評 [21/26]
    李秀珠 [75/105]
    李靜琪 [23/24]
    林書玉 [19/20]
    洪明秀 [31/40]
    潘秀玲(2009-2013) [16/17]
    王文傑 [13/15]
    王鴻俊 [7/7]
    石全(2014-2017) [35/39]
    童俊維 [23/23]
    紀雅惠 [21/25]
    翁紹華 [22/24]
    莊宏 [1/1]
    葉修華 [24/25]
    葉燈光 [133/152]
    蔣維棠 [41/66]
    謝興邦 [171/231]
    趙宇生(2002-2013) [120/212]
    郭靜娟 [49/55]
    鄒倫 [28/29]
    陳志豪 [31/52]
    陳新(2002-2015) [53/67]
    陳炯東 [180/212]
    顏婉菁 [6/7]
    許明珠(1997-2001) [3/10]
    陳淑貞(1998-2001) [3/11]
    陳華鍵(1997-2001) [9/9]

    社群统计


    近3年内发表的文件:9(4.19%)
    含全文笔数:170(79.07%)

    文件下载次数统计
    下载大于0次:170(100.00%)
    下载大于100次:168(98.82%)
    全文下载总次数:103300(1.93%)

    最后更新时间: 2024-12-01 08:48

    上传排行

    数据加载中.....

    下载排行

    数据加载中.....

    RSS Feed RSS Feed
    跳至:
    或输入年份:
    由新到旧排序 由最旧的开始

    显示项目51-75 / 215. (共9页)
    << < 1 2 3 4 5 6 7 8 9 > >>
    每页显示[10|25|50]项目

    日期题名關聯
    2015-08 Optimization of quinazoline-based kinase inhibitors: Identification of a dual FLT3/AURKA kinase inhibitor for the treatment of acute myeloid leukemia Abstracts of Papers of the American Chemical Society. 2015 Aug;250:Meeting Abstract 490.
    2015-08 Discovery of 2,4-diaminopyrimidines bearing a unique pharmacophore as anaplastic lymphoma kinase inhibitors Abstracts of Papers of the American Chemical Society. 2015 Aug;250:Meeting Abstract 182.
    2015-07-31 作為極光激酶抑制劑的稠合雙環嘧啶化合物 HK1151694/2015-07-31
    2015-07-22 作为酪胺酸激酶抑制剂的稠合双环及多环嘧啶化合物 ZL200980144458.1/2015-07-22
    2015-07 Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutations European Journal of Medicinal Chemistry. 2015 Jul;100:151-161.
    2015-06-29 Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification Scientific Reports. 2015 Jun 29;5:Article number 11702.
    2015-06-16 Anchor-based classification and type-C inhibitors for tyrosine kinases Scientific Reports. 2015 Jun 16;5:Article number 10938.
    2015-01-02 KUD773, a phenylthiazole derivative, displays anticancer activity in human hormone-refractory prostate cancers through inhibition of tubulin polymerization and anti-Aurora A activity Journal of Biomedical Science. 2015 Jan 2;22:Article number 2.
    2015-01 Identification of ligand efficient, fragment-like hits from an HTS library: Structure-based virtual screening and docking investigations of 2H- and 3H-pyrazolo tautomers for Aurora kinase A selectivity Journal of Computer-Aided Molecular Design. 2015 Jan;29(1):89-100.
    2014-12 BPR-3P0128 inhibits RNA-dependent RNA polymerase elongation and VPg uridylylation activities of Enterovirus 71 Antiviral Research. 2014 Dec;112:18-25.
    2014-11-20 The combination effects of LiCl and the active leflunomide metabolite, A771726, on viral-induced interleukin 6 production and EV-A71 replication PLoS ONE. 2014 Nov 20;9(11):Article number e111331.
    2014-11 Reticulon 3 interacts with NS4B of the hepatitis C virus and negatively regulates viral replication by disrupting NS4B self-interaction Cellular Microbiology. 2014 Nov;16(11):1603-1618.
    2014-11 Discovery of multiple kinases inhibitors, DBPR114, as the novel anti-cancer agent European Journal of Cancer. 2014 Nov;50(Suppl. 6):92-93.
    2014-10-29 作為極光激酶抑制劑的稠合雙環嘧啶化合物 ZL200980115577.4/2014-10-29
    2014-10-21 化合物於製造治療病毒感染的藥物之用途 I457121/2014-10-21
    2014-10 Optimization of 5,6-fused pyrimidine-based kinase inhibitors by computer-aided drug design for the treatment of AML Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 2530.
    2014-10 Novel irreversible EGFR tyrosine kinase inhibitor, DBPR112, as a therapeutic candidate for lung adenocarcinoma Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 1756.
    2014-08 Ligand efficiency based approach for efficient virtual screening of compound libraries European Journal of Medicinal Chemistry. 2014 Aug;83:226-235.
    2014-05 Facile identification of dual FLT3-Aurora A inhibitors: A computer-guided drug design approach ChemMedChem. 2014 May;9(5):953-961.
    2014-05 Cover Picture: Facile identification of dual FLT3–aurora a inhibitors: A computer-guided drug design approach (ChemMedChem 5/2014) ChemMedChem. 2014 May;9(5):861.
    2014-04-29 Quinoline compounds and their use for treating viral infection US8710079B2/2014-04-29
    2014-04-21 作為蛋白質激酶抑制劑之吡唑化合物及噻唑化合物、其醫藥組成物及用途 I434834/2014-04-21
    2014-03-20 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors JP5502072/2014-03-20
    2014-03 DBPR112, a potent and selective EGFR kinase inhibitor in preclinical study Abstracts of Papers - American Chemical Society. 2014 Mar;247:Article number 315-MEDI.
    2014-03 Efficient virtual screening using ligand efficiency based approach Abstracts of Papers - American Chemical Society. 2014 Mar;247:Article number 55-MEDI.

    显示项目51-75 / 215. (共9页)
    << < 1 2 3 4 5 6 7 8 9 > >>
    每页显示[10|25|50]项目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈